Cholestatic Drug-induced Liver Injury

计划入组 180 人 · 首次发布于 2010 年 6 月 10 日

Drug-induced Liver Injury: Itching Study

计划入组 50 人 · 首次发布于 2024 年 6 月 6 日

Drug-Induced Liver Injury (DILI) Network Retrospective

计划入组 400 人 · 首次发布于 2006 年 8 月 4 日

drug candidates (neonatal brain injury)

undisclosed drug (fibrotic liver disease/NASH), Engitix/Takeda

Covalent Induced Drug Conjugates(Tesseract)

LIVER INSTITUTE PLLC

United States

National Liver Institute

Egypt

National Liver Institute, Egypt

FDA Accepts AI-Based Digital Liver Model into ISTAND Program to Predict Drug-Induced Liver Injury

Expert Consensus Provides Guidance on Drug-Induced Liver Injury in Oncology Trials

Genencell COVID-19 Drug ES16001 Approved for Phase 2/3 Without Liver-Injury Endpoint Despite Phase 1 Enzyme Elevations